{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000055","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.433290+00:00","generated_at":"2026-06-01T06:17:17.881129+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BeiGene shareholders approve equity plan share increases and director re-elections at AGM","bullets":["Approved Third Amended 2016 Share Option Plan, adding 92.82M shares to the reserve.","Approved Fourth Amended 2018 ESPP, increasing share availability by 5.07M shares.","Re-elected Class II directors Brandicourt, Glazer, Goller, Sanders with strong support.","Approved general mandates to issue up to 20% and repurchase up to 10% of shares.","Approved RSUs and PSUs to CEO John Oyler ($6M each) and other executive grants."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000055","json":"https://secwatch.observer/filing/0001651308-24-000055.json","markdown":"https://secwatch.observer/filing/0001651308-24-000055.md","text":"https://secwatch.observer/filing/0001651308-24-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000055/0001651308-24-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000055/bgne-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:17:17.881129+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}